Euroopa Liit -
eesti -
EMA (European Medicines Agency)
piqray
novartis europharm limited - alpelisib - rinnanäärmed - antineoplastilised ained - piqray on näidustatud kombinatsioonis fulvestrant raviks postmenopausis naistele, meestele ja hormooni retseptori (hr)-positiivne, inimese epidermaalse kasvufaktori retseptor 2 (her2)-negatiivne, lokaalselt kaugelearenenud või metastaatilise rinnavähi koos pik3ca mutatsiooni pärast haiguse progresseerumise pärast sisesekretsioonisüsteemi ravi monotherapy (vt lõik 5.
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaktsiinid - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
klisyri
almirall, s.a. - tirbanibulin - keratoos, actinic - antibiootikumid ja kemoterapeutikumid dermatoloogiliseks kasutamiseks - klisyri is indicated for the field treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis (olsen grade 1) of the face or scalp in adults.
Eesti -
eesti -
Ravimiamet
thiamacare suukaudne lahus
ecuphar - tiamasool - suukaudne lahus - 10mg 1ml 30ml 1tk
Eesti -
eesti -
Ravimiamet
cortotic kõrvasprei, lahus
virbac - hüdrokortisoon - kõrvasprei, lahus - 0,584mg 1ml 16ml 1tk
Euroopa Liit -
eesti -
EMA (European Medicines Agency)
opzelura
incyte biosciences distribution b.v. - ruxolitinib phosphate - vitiligo - muud dermatoloogilised preparaadid - opzelura is indicated for the treatment of non-segmental vitiligo with facial involvement in adults and adolescents from 12 years of age.
Eesti -
eesti -
Adama
tomahawk® 200 ec
adama - emulsioonikontsentraat - fluroksüpüür - herbitsiidid